Literature DB >> 9093833

Experimental pathogenicity of viscerotropic and dermotropic isolates of Leishmania infantum from immunocompromised and immunocompetent patients in a murine model.

A Sulahian1, Y J Garin, F Pratlong, J P Dedet, F Derouin.   

Abstract

The pathogenicity of 22 strains of Leishmania infantum from 11 HIV-infected and 11 immunocompetent patients with visceral (VL, n = 16) or cutaneous (CL, n = 6) leishmaniasis, belonging to 3 zymodemes (MON-1, n = 14; MON-29, n = 5; MON-33, n = 3), was studied using a murine model. For each strain 16-20 BALB/c mice were infected at day 0 (d0) by i.v. injection of 10(7) stationary-phase promastigotes. Parasite burdens were quantified in the spleen and liver of 4-5 mice of each strain at d7, d20, d60 and d90 or d100, using a sensitive culture microtitration technique. A great variability of infection profiles between strains was observed: (i) six strains showed a progressive infection, with a predominance of hepatic parasites at d7 or d20 (10(4)-10(6) g-1), then a continuous rise of splenic parasites reaching 10(5)-10(7) g-1 at d90 or d100 contrasting with a stagnation or decrease in the liver; (ii) ten strains gave a controlled infection with hepatic parasite burden reaching 10(4)-10(5) g-1 at d7 or d20, followed by a more or less rapid decline leading frequently to no detectable parasites; (iii) six strains resulted in other profiles, i.e., undetectable infection (n = 1) or low parasite loads (n = 4), or late occurrence of parasites in the spleen (n = 1). No relationship was observed between profile and growth characteristics in vitro or zymodeme of the strain. Strains originating from CL never gave a visceralizing pattern in mice, but belonged more frequently to the avirulent type compared to VL strains. Strains from HIV-infected patients were not less virulent than those from immunocompetent individuals. These results showed that the course of L. infantum infection varies markedly with intrinsic parasite factors that display striking intraspecific variability.

Entities:  

Mesh:

Year:  1997        PMID: 9093833     DOI: 10.1111/j.1574-695X.1997.tb01005.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  13 in total

1.  Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice.

Authors:  S Bretagne; R Durand; M Olivi; J F Garin; A Sulahian; D Rivollet; M Vidaud; M Deniau
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

2.  Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections.

Authors:  Y J Garin; A Sulahian; F Pratlong; P Meneceur; J P Gangneux; E Prina; J P Dedet; F Derouin
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis.

Authors:  R Durand; M Paul; F Pratlong; D Rivollet; M L Dubreuil-Lemaire; R Houin; A Astier; M Deniau
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

4.  Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis.

Authors:  Saeed Ahmed; M Colmenares; L Soong; K Goldsmith-Pestana; L Munstermann; R Molina; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

5.  Association between skin parasitism and a granulomatous inflammatory pattern in canine visceral leishmaniosis.

Authors:  Washington L C dos-Santos; John David; Roberto Badaró; Luiz A R de-Freitas
Journal:  Parasitol Res       Date:  2003-11-11       Impact factor: 2.289

6.  Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis.

Authors:  Joana Cunha; Eugenia Carrillo; Carmen Sánchez; Israel Cruz; Javier Moreno; Anabela Cordeiro-da-Silva
Journal:  Parasit Vectors       Date:  2013-04-26       Impact factor: 3.876

Review 7.  Visceral leishmaniasis in Ethiopia: an evolving disease.

Authors:  Samson Leta; Thi Ha Thanh Dao; Frehiwot Mesele; Gezahegn Alemayehu
Journal:  PLoS Negl Trop Dis       Date:  2014-09-04

Review 8.  Study of Leishmania pathogenesis in mice: experimental considerations.

Authors:  Corinne Loeuillet; Anne-Laure Bañuls; Mallorie Hide
Journal:  Parasit Vectors       Date:  2016-03-11       Impact factor: 3.876

9.  Knowledge, attitude and practices related to visceral leishmaniasis among residents in Addis Zemen town, South Gondar, Northwest Ethiopia.

Authors:  Agersew Alemu; Abebe Alemu; Nuraini Esmael; Yared Dessie; Kedir Hamdu; Biniam Mathewos; Wubet Birhan
Journal:  BMC Public Health       Date:  2013-04-24       Impact factor: 3.295

Review 10.  Determinants for the development of visceral leishmaniasis disease.

Authors:  Laura-Isobel McCall; Wen-Wei Zhang; Greg Matlashewski
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.